Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

COYA Coya Therapeutics Inc

5,713

-0,137 (-2,34%)

Zuletzt aktualisiert: 15:49:33

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Coya Therapeutics (NASDAQ:COYA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Coya Therapeutics Charts.

Coya Therapeutics (NASDAQ:COYA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Coya Therapeutics Charts.

News Coya Therapeutics Inc

Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
Dienstag 21 Januar 2025 (1 Woche vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)
Mittwoch 18 Dezember 2024 (1 Monat vor) • Business Wire

Form EFFECT - Notice of Effectiveness
Montag 2 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 29 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference
Montag 25 November 2024 (2 Monate vor) • Business Wire

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 20 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Dienstag 19 November 2024 (2 Monate vor) • Business Wire

Weitere Coya Therapeutics Inc News-Artikel

Euro vs Sterling

Deutsche Lufthansa

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen